Heart Test Laboratories, Inc. (HSCS)
NASDAQ: HSCS · IEX Real-Time Price · USD
0.107
-0.001 (-1.29%)
Apr 19, 2024, 1:13 PM EDT - Market open
Heart Test Laboratories Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for HSCS.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for HSCS.
Recommendation Trends
Rating | Sep '22 | Oct '22 | Nov '22 | Dec '22 | Jan '23 |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 1 | 1 | 0 |
Buy | 1 | 1 | 1 | 1 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $3.3 | Strong Buy | Initiates | $3.3 | +2,981.23% | Jan 30, 2023 |
Maxim Group | Maxim Group | Strong Buy Maintains $8 → $3 | Strong Buy | Maintains | $8 → $3 | +2,701.12% | Dec 19, 2022 |
Maxim Group | Maxim Group | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +7,369.65% | Nov 9, 2022 |
Benchmark | Benchmark | Buy Initiates $8 | Buy | Initiates | $8 | +7,369.65% | Aug 8, 2022 |
Financial Forecast
Revenue This Year
60.49K
from 5.15K
Increased by 1,074.49%
Revenue Next Year
1.94M
from 60.49K
Increased by 3,104.05%
EPS This Year
-0.20
from -0.80
EPS Next Year
-0.11
from -0.20
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 105,000 | 3.4M | 12.1M |
Avg | 60,486 | 1.9M | 11.7M |
Low | 18,228 | 588,000 | 11.3M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 1,938.8% | 5,455.0% | 523.1% |
Avg | 1,074.5% | 3,104.0% | 505.3% |
Low | 253.9% | 872.1% | 481.5% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.20 | -0.09 | - |
Avg | -0.20 | -0.11 | - |
Low | -0.21 | -0.12 | - |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.